A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

NCT07475572 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: AVT32-DRL_PB
BIOLOGICAL: Keytruda

Sponsor

Alvotech Swiss AG

Collaborators

[object Object]